New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

Web News

The CellCarta–Leica Biosystems Partnership: A Coordinated Approach to CDx Development in China

May 8, 2026

More info

Posters

High quality whole transcriptome RNA-sequencing from challenging clinical samples

April 21, 2026

More info

Posters

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

April 20, 2026

More info

Brochures & Infographics

Genomic Assay List

April 15, 2026

More info